Body Mass Index, Fat Percentage Predict Menses Resumption

This article originally appeared here.
Share this content:
Body Mass Index, Fat Percentage Predict Menses Resumption
Body Mass Index, Fat Percentage Predict Menses Resumption

WEDNESDAY, Aug. 31, 2016 (HealthDay News) -- For patients with a history of anorexia nervosa, both body mass index and fat percentage can predict resumption of the menstrual cycle, according to a study published online Aug. 29 in the International Journal of Eating Disorders.

Laura Al-Dakhiel Winkler, M.D., from Odense University Hospital in Denmark, and colleagues examined the correlation between body composition measures and menstrual status in 113 women with a history of anorexia nervosa. Participants underwent a dual-energy X-ray absorptiometry scan and completed questionnaires relating to medication prescription and menstrual function.

The researchers found that 50 percent of participants were expected to resume menstrual function at a body mass index of 19 kg/m² or a fat percentage of 23 percent. The expected resumption of menstrual function was at a body mass index of 14 kg/m² or a fat percentage of 11 percent for 25 percent of participants. Prediction of resumption of menses was equivalent for body mass index and fat percentage.

"Fat percentage and body mass index were positive predictors of the resumption of menses; however, body composition measured by dual energy X-ray absorptiometry was not superior to body mass index in predicting menstrual recovery, which is of great clinical relevance as body mass index is easier and cheaper to obtain," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »